Target intelligence / Profile preview

DNA topoisomerase 1–DNA cleavage complex (Top1-DNA CC) (Top1-DNA CC)

Target
Top1-DNA CC
Molecular classification
Enzyme-DNA complex, Type IB topoisomerase, Enzyme
01

Overview

The DNA topoisomerase 1–DNA cleavage complex (Top1-DNA CC) is a transient catalytic intermediate formed during the action of the enzyme DNA topoisomerase 1. Under normal physiological conditions, Top1 relieves torsional strain in DNA by creating a reversible single-strand break, forming a covalent bond between a tyrosine residue and the 3' phosphate of the DNA backbone [1, 2]. This allows the DNA to rotate and relax before the enzyme re-ligates the strand. However, this complex becomes a potent therapeutic target when stabilized by specific inhibitors, such as camptothecin derivatives [1, 3]. These drugs act as interfacial inhibitors, trapping the Top1-DNA CC and preventing the re-ligation step [2]. When DNA replication forks or transcription machinery encounter these stabilized complexes, they are converted into permanent, lethal double-strand breaks, ultimately triggering programmed cell death [1, 3]. This mechanism is widely exploited in oncology for the treatment of various solid tumors, including colorectal and ovarian cancers [1, 4]. Citations: [1] Pommier Y. (2006). Nature Reviews Cancer. [2] Pommier Y. (2013). ACS Chemical Biology. [3] Thomas C. J., et al. (2004). Bioorganic & Medicinal Chemistry. [4] UniProt (2024). P11387 (TOP1_HUMAN).

Other names
Top1ccTopoisomerase I-DNA covalent complexTop1-DNA covalent complexTop1-DNA adductTop1 cleavage complex
02

Mechanism of action

Interfacial inhibition; stabilization of the covalent Top1-DNA intermediate to prevent re-ligation, resulting in replication-mediated DNA double-strand breaks.

03

Biological functions

DNA relaxationDNA replicationTranscriptionDNA topological maintenanceCell cycle regulationApoptosis
04

Disease associations

Cancer
05

Safety considerations

MyelosuppressionGastrointestinal toxicity (severe diarrhea)NeutropeniaSecondary malignanciesTrapping-induced DNA damage in healthy tissues
06

Interacting drugs

Irinotecan

7 more in the full profile.

07

Biomarkers

SLFN11 expressionTDP1 activityTop1 protein levelsXRCC1 expression

Beyond the preview

Go deeper on DNA topoisomerase 1–DNA cleavage complex (Top1-DNA CC) (Top1-DNA CC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA topoisomerase 1–DNA cleavage complex (Top1-DNA CC) (Top1-DNA CC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call